Futura Medical Share Discussion Threads

[lbo] 08/9/2022 10:06

Any update on an enforceable patent? LOL



The Company has conducted initial literature and in vitro based research that has shown the cooling from the evaporation of these specific combinations of solvents’



There is a risk that some claims will either be challenged in future (eg on the grounds of non-obviousness or existence of prior art) and/or that another technology may be employed to achieve a similar effect. The protracted development times mean the clock has been ticking on the original issued patents, reducing the protected commercial products




A smooth gel intended for alcohol soluble actives. Provides cooling effect upon application while leaving minimal residue




The cooling effect of a topically applied product can be evaluated using a validated handheld thermal imaging system. When the gel matrix is destroyed after application to the skin, the bound water and alcohol evaporates and a measurable cooling-effect results.

[broomrigg] 08/9/2022 09:03

Shares looking lively again this morning :-)

[mike2042] 07/9/2022 23:02

Still pontificating nonsense LBO, now you are attempting to filibuster away at the contractual history. What about your original inane points about how the product is the key flaw and our investments are doomed… YAWN, c’mon write us all again that the company is doomed.

[lbo] 07/9/2022 20:20

Long standing shareholders learned from Futura what clauses have been in previous deals that favour their partners. Just to get the deals signed and announced. But allows the partners to never have to launch or if they do launch never have to pay any real royalties. There was Zero value in every so called ‘global partner seller contracts FUM have signed’ since 2003. And even just allow partners to hand back the rights with no real penalties after sitting on the rights and running down any patents eg Reckitt and CSD500. Or what shareholders remember the deal with Kabey who was supposedly ‘well established’ group and ‘exciting times’ were ahead! Yet Kabey itself no longer even exists! LOL












a agreed percentage of the net sales value (after transport costs, sales tax, credit notes for returns and defective products and any settlement, retrospective, volume and promotional discounts) charged by LRC or any sub-licensee in relation to the Product.

The royalty and the royalty advance may be reduced by such amount (if any) as is agreed or determined by an expert to be fair and reasonable if: (i) any patent application does not proceed to grant or any patent rights are determined to be unenforceable or are revoked or lapse; or (ii) an event occurs which in LRC reasonable opinion adversely affects the commercial viability of the licence agreement or the margins on sales of the Product; or (iii) a competing product is offered for

[mike2042] 07/9/2022 19:46

You are a paid deramper LBO nothing more, the global partner seller contracts FUM have signed indicate value of MED3000. You are spreading disinformation to prompt sale of shares by retail investors, happens all the time to penny stocks on AIM.

YAWN - quick, quick find more articles from 2015 to get us discouraged.

[lbo] 07/9/2022 19:29

So the research Futura itself references on its website is now a ‘load of tosh’! ROFlMAO



˜lack of efficacy represented the most important reasons for PDE5i discontinuation’

[lbo] 07/9/2022 15:15

Even Futura’s own linked research says one of the main reasons for discontinuation of Oral PDE5i is efficacy. Yet FM71 has shown Med3000 has even less efficacy then Tadalafil



˜lack of efficacy represented the most important reasons for PDE5i discontinuation’

Other reasons for discontinuing vary by geography and age-group, ranging from a lack of desire and/or opportunity to a partners loss of libido, and is probably related to individual cultural and psycho-social factors rather then anything to do with the Oral PDE5i.

And if Med3000 ‘works’ for anyone then so will an arousal gel! LOL

[lbo] 07/9/2022 14:28

But unfortunately it does to need be proven to substantiate its marketing claims or fall foul of the FTC, ASA and the Courts. LOL



A product that contemporary technology does not understand must establish that this ‘magic’ actually works. Proof is what separates an effect new to science from a swindle . . . . If a condition responds to treatment, then selling a placebo as if it had therapeutic effect directly injures the consumer. FTC v. QT, Inc., 512 F.3d 858, 862-63 (7th Cir.

[lbo] 07/9/2022 12:16

Trinity Research even admit the hypothesised effects 'believed' to be happening by Futura are 'disputed' and Trinity admitted no mechanism of action has to be even shown to get a medical device approved. LOL But unfortunately it does to need be proven to substantiate its marketing claims or fall foul of the FTC, ASA and the Courts.https://www.ftc.gov/system/files/documents/public_statements/996984/p114505_otc_homeopathic_drug_enforcement_policy_statement.pdfA product that contemporary technology does not understand must establish that this 'magic' actually works. Proof is what separates an effect new to science from a swindle . . . . If a condition responds to treatment, then selling a placebo as if it had therapeutic effect directly injures the consumer. FTC v. QT, Inc., 512 F.3d 858, 862-63 (7th Cir.Trinity research:Presumably the effect is comparable to the cold-induced vasodilation (CIVD) that occurs with extremities such as toes and fingers. Despite being a well-known effect, the mechanisms of CIVD are still disputed, but the pathways involved could well be similar. Interestingly, the precise mechanism of action does not need to be elucidated for the regulators to be comfortable for a product to be approved as medical devicehttps://www.discovermagazine.com/health/the-erection-of-a-placeboThere is no evidence for the evaporative mode of action from the clinical trials. To show that the evaporation is what makes MED3000 work, you'd need to compare it to a non-evaporative gel